Jiangsu Aidea Pharmaceutical Co., Ltd. (688488.SS)
CNY 8.87
(2.31%)
CNY 8.87
(2.31%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.74 Billion CNY | 5.52% |
| 2022 | 1.65 Billion CNY | 15.38% |
| 2021 | 1.43 Billion CNY | -0.84% |
| 2020 | 1.44 Billion CNY | 85.26% |
| 2019 | 780.98 Million CNY | 10.16% |
| 2018 | 708.94 Million CNY | 7.54% |
| 2017 | 659.23 Million CNY | 48.63% |
| 2016 | 443.55 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 1.92 Billion CNY | 15.57% |
| 2024 Q1 | 1.75 Billion CNY | 0.34% |
| 2024 Q2 | 1.66 Billion CNY | -4.79% |
| 2023 Q3 | 1.79 Billion CNY | 0.02% |
| 2023 Q4 | 1.74 Billion CNY | -2.92% |
| 2023 FY | 1.74 Billion CNY | 5.52% |
| 2023 Q1 | 1.69 Billion CNY | 2.57% |
| 2023 Q2 | 1.79 Billion CNY | 5.95% |
| 2022 Q4 | 1.65 Billion CNY | 2.37% |
| 2022 Q3 | 1.61 Billion CNY | 1.3% |
| 2022 Q2 | 1.59 Billion CNY | 6.36% |
| 2022 FY | 1.65 Billion CNY | 15.38% |
| 2022 Q1 | 1.5 Billion CNY | 4.6% |
| 2021 Q4 | 1.43 Billion CNY | 0.4% |
| 2021 Q3 | 1.42 Billion CNY | -1.58% |
| 2021 Q2 | 1.45 Billion CNY | -0.73% |
| 2021 Q1 | 1.46 Billion CNY | 1.09% |
| 2021 FY | 1.43 Billion CNY | -0.84% |
| 2020 Q2 | 707.97 Million CNY | -4.31% |
| 2020 FY | 1.44 Billion CNY | 85.26% |
| 2020 Q4 | 1.44 Billion CNY | 3.03% |
| 2020 Q3 | 1.4 Billion CNY | 98.36% |
| 2020 Q1 | 739.87 Million CNY | -5.26% |
| 2019 Q4 | 780.98 Million CNY | 0.0% |
| 2019 FY | 780.98 Million CNY | 10.16% |
| 2019 Q2 | 755.63 Million CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | 708.94 Million CNY | 7.54% |
| 2017 FY | 659.23 Million CNY | 48.63% |
| 2016 FY | 443.55 Million CNY | 0.0% |